An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)

An Investigation of Interactions Between Genetic Variants and Established Risk Factors for Breast Cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)

Bibliografske podrobnosti
Main Authors:	Campa, D, Kaaks, R, Le Marchand, L, Haiman, C, Travis, R, Ziegler, R, Hunter, D, Lindstroem, S, Canzian, F
Format:	Conference item
Izdano:	2012

Podobne knjige/članki

Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
od: Tsilidis, K, et al.
Izdano: (2013)

Common genetic variants in prostate cancer risk prediction--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
od: Lindström, S, et al.
Izdano: (2012)

Quantitative trait loci predicting circulating sex steroid hormones in men from the NCI-Breast and Prostate Cancer Cohort Consortium (BPC3).
od: Ahn, J, et al.
Izdano: (2009)

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
od: Setiawan, V, et al.
Izdano: (2007)

A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
od: Cox, D, et al.
Izdano: (2006)

Genetic polymorphisms of the <it>GNRH1 </it>and <it>GNRHR </it>genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)
od: Lund Eiliv, et al.
Izdano: (2009-07-01)

IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
od: Patel, A, et al.
Izdano: (2008)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium
od: Campa, D, et al.
Izdano: (2011)

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
od: Campa, D, et al.
Izdano: (2011)

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.
od: Mondul, A, et al.
Izdano: (2013)

Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women.
od: Barrdahl, M, et al.
Izdano: (2014)

Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium.
od: Joshi, A, et al.
Izdano: (2014)

Association of type 2 diabetes susceptibility variants with advanced prostate cancer risk in the Breast and Prostate Cancer Cohort Consortium.
od: Machiela, M, et al.
Izdano: (2012)

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
od: Chen, Y, et al.
Izdano: (2007)

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
od: Lindstrom, S, et al.
Izdano: (2011)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
od: Shui, I, et al.
Izdano: (2014)

A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
od: Lindström, S, et al.
Izdano: (2010)

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
od: Travis, R, et al.
Izdano: (2009)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium
od: Shui, I, et al.
Izdano: (2014)

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
od: Sara Lindstrom, et al.
Izdano: (2011-02-01)

Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
od: Mathew, Angelin Tresa, et al.
Izdano: (2022)

Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
od: Mathew, Angelin T., et al.
Izdano: (2022)

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.
od: Agarwal, D, et al.
Izdano: (2014)

Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
od: Tsilidis, K, et al.
Izdano: (2012)

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium.
od: Milne, R, et al.
Izdano: (2014)

Characteristics of Breast Cancer at First Presentation in Sudanese Patients Attending the National Cancer Institute–University of Gezira (NCI–UG)
od: Muna Ahmed Eltayeb, et al.
Izdano: (2020-08-01)

Characteristics of Breast Cancer at First Presentation in Sudanese Patients Attending the National Cancer Institute–University of Gezira (NCI–UG)
od: Muna Ahmed Eltayeb, et al.
Izdano: (2020-08-01)

Haplotypes of the estrogen receptor beta gene and breast cancer risk.
od: Cox, D, et al.
Izdano: (2008)

Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.
od: Koutros, S, et al.
Izdano: (2010)

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
od: Yang, X, et al.
Izdano: (2011)

Rational Design of Cyclic Antimicrobial Peptides Based on BPC194 and BPC198
od: Anna D. Cirac, et al.
Izdano: (2017-06-01)

Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium.
od: Jirong Long, et al.
Izdano: (2010-06-01)

A common 8q24 variant in prostate and breast cancer from a large nested case-control study.
od: Schumacher, F, et al.
Izdano: (2007)

The role of osteoprotegerin in breast and prostate cancer
od: Holen, I, et al.
Izdano: (2002)

The impact of transcription on metabolism in prostate and breast cancers
od: Poulose, N, et al.
Izdano: (2018)

Frequency of breast cancer subtypes among African American women in the AMBER consortium
od: Emma H. Allott, et al.
Izdano: (2018-02-01)

Nutrition and breast cancer.
od: Key, T, et al.
Izdano: (2003)

A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
od: Foluso O. Ademuyiwa, et al.
Izdano: (2022-12-01)

The functional ALDH2 polymorphism is associated with breast cancer risk: A pooled analysis from the Breast Cancer Association Consortium
od: Tomotaka Ugai, et al.
Izdano: (2019-06-01)

Oestrogen exposure and breast cancer risk.
od: Travis, R, et al.
Izdano: (2003)